Stocksigma LogoStocksigma Logo

Biofil Chemicals to Consider Q2 Results on 14th Nov'26

Biofil Chemicals and Pharmaceuticals Limited has scheduled a Board of Directors meeting on 14th Nov'26

Biofil Chemicals to Consider Q2 Results on 14th Nov'26

Biofil Chemicals & Pharmaceuticals Ltd 路 Intimation 路 14 Nov 2026, 5:30 am

Biofil Chemicals to Consider Q2 Results on 14th Nov'26 Biofil Chemicals and Pharmaceuticals Limited has scheduled a Board of Directors meeting on 14th Nov'26. The board will consider and approve the un-audited financial results of the company for the quarter and half-year ended 30th Sep'26, alongside the Limited Review Report. Additionally, in compliance with SEBI insider trading regulations, the trading window for dealing in company securities remains closed and will reopen 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Biofil Chemicals & Pharmaceuticals Ltd

All Biofil Chemicals & Pharmaceuticals Ltd announcements